z
zeshancemb

Muhammad Z

@zeshancemb

PhD Candidate Cancer Immunology and Molecular Oncology

Taiwan
Englisch, Urdu
Einige Informationen werden in englischer Sprache angezeigt.
Über mich
I am a Ph.D. researcher in cancer immunology and molecular oncology with expertise in tumor–immune interactions and translational cancer research. My work focuses on the molecular mechanisms regulating anti-tumor immunity, T-cell function, and immunotherapy, including CAR-T cell approaches, to support the development of improved cancer treatments.... Mehr lesen

Kompetenzen

z
zeshancemb
Muhammad Z
offline • 
Durchschnittliche Antwortzeit: 1 Stunde

Meine Dienstleistungen

Bulk-Artikel
I will write, edit, and proofread scientific cancer research

Portfolio

Arbeitserfahrung

University_of Houston

Research scholar

University of Houston • Vollzeit

Sep 2021 - Present • 5 yrs 1 mo

Serving as a doctoral researcher and T-STAR Fellow in the Department of Biomedical Sciences. Focuses on translational cancer immunology, investigating the molecular regulators of immune synapse stability, T-cell exhaustion, and strategies to potentiate CAR-T cell immunotherapy. Key research addresses novel checkpoint pathways—including the Galectin-9/CD58 axis—alongside collaborative work on targeted combination therapies in solid tumors. Regularly presents scientific discoveries at international symposia, actively publishes in peer-reviewed scientific journals, and received the 1st Prize Outstanding Graduate Student Award at CMU.

Shaukat_Khanum Memorial Cancer Hospital and Research Centre

Research Associate

Shaukat Khanum Memorial Cancer Hospital and Research Centre • Vollzeit

Aug 2018 - Aug 2021 • 3 yrs

Worked as a Research Associate Level-II in translational cancer research at SKMCH&RC. Contributed to oncology investigations focused on tumor biomarkers, clinicopathological risk factors, and prognostic outcomes in solid tumors, including oral squamous cell carcinoma and colon cancer. Collaborated with scientists and clinicians on study design, sample processing, and data analysis, generating peer-reviewed publications in international oncology journals.